DEREK ERSTAD to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications DEREK ERSTAD has written about Xenograft Model Antitumor Assays.
Connection Strength
0.157
-
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI. Clin Cancer Res. 2020 09 15; 26(18):5007-5018.
Score: 0.132
-
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition. Cancer Cell. 2016 Dec 12; 30(6):879-890.
Score: 0.026